Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DUSP8 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | SOX12 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | SPTBN4 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
mRNA | ST18 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
mRNA | IGFBPL1 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | MED28 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
mRNA | PHLPP1 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
mRNA | ZNF324 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
mRNA | FAM69B | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
mRNA | TNPO2 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |